• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home StudyGraphics

#VisualAbstract: Hydroxychloroquine in Nonhospitalized Adults With Early COVID-19

byConstance Wu
July 28, 2020
in StudyGraphics
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. In this double-blind, randomized trial, hydroxychloroquine did not reduce symptom severity in an adult, outpatient population.

2. More side effects, mainly gastrointestinal symptoms, were experienced by the patients in the treatment group.

Evidence Rating Level: 1 (Excellent)

Study Rundown: There are currently no effective oral therapies for the outpatient treatment of COVID-19. This trial aimed to assess whether hydroxychloroquine could reduce symptom severity of COVID-19 in an adult, outpatient population. Eligibility for the trial included patients with fewer than four days of symptoms, confirmed or high-risk exposure to SARS-CoV-2 and was non-hospitalized. Over the 14 days, hydroxychloroquine treatment did not demonstrate any significant improvement in symptom severity. The treatment group also experienced greater side effects, the most common were GI symptoms. The study was one of the first to investigate outpatient treatment for COVID-19 and underscores an area of unmet need. Limitations of this study included the lack of confirmed SARS-CoV-2 infection in all participants due to a severe shortage in testing kits however, only a minority who did not have COVID-19 contributed to the primary study outcome.

Click here to read the study in Annals of Internal Medicine

Click to read an accompanying editorial in Annals in Internal Medicine

In-Depth [randomized controlled trial]: In this randomized, double-blind, placebo-controlled trial, 491 patients were included and 423 contributed to the primary endpoint. 56% were enrolled within 1 day of symptom onset. Patients were randomized to either hydroxychloroquine (800 mg PO once, followed by 600 mg in 6-8 hrs, then 600 mg daily for 4 days) or placebo. The difference in symptom severity was insignificant over the 14 days (absolute difference: −0.27 points on 10-point scale, [95% CI, −0.61 to 0.07 points], p = 0.117). At the 14-day mark, there was no statistical difference in the proportion of patients still experiencing symptoms (p = 0.21). Medication adherence (threshold of 75% adherence) did not influence symptom severity (-2.57 points vs. -2.70 points). Adverse effects occurred in 43% of patients in the hydroxychloroquine group versus 22% in placebo (p < 0.001) which mainly consisted of GI symptoms such as nausea, upset stomach, vomiting, abdominal pain, and diarrhea. 16% of patients contributing data to the primary endpoint had a confirmed negative PCR test. Taken together, symptom severity in patients with early and mild COVID-19 was not reduced in those taking Hydroxychloroquine.

RELATED REPORTS

#VisualAbstract: Molnupiravir improves outcomes in non-hospitalized COVID-19 patients

Risk of myocarditis or pericarditis after COVID-19 mRNA vaccination is highest among younger males

Vaccination boosted immunity acquired from previous SARS-CoV-2 infection

Image: PD

©2020 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: hydroxychloroquineSARS-CoV-2
Previous Post

No association between influenza vaccine exposure in utero and adverse childhood health outcomes

Next Post

A sibling-adoption design for the study of genetic and environmental influence on children’s body mass index #TA

RelatedReports

#VisualAbstract: Molnupiravir improves outcomes in non-hospitalized COVID-19 patients
StudyGraphics

#VisualAbstract: Molnupiravir improves outcomes in non-hospitalized COVID-19 patients

June 30, 2022
Atrial fibrillation-specific management increases days alive and out of hospital
Cardiology

Risk of myocarditis or pericarditis after COVID-19 mRNA vaccination is highest among younger males

June 22, 2022
Decreased expression of nasal ACE2 may be correlated with lower prevalence of COVID-19 in children
Chronic Disease

Vaccination boosted immunity acquired from previous SARS-CoV-2 infection

May 13, 2022
Novel coronavirus identified from patients with pneumonia in Wuhan, China
Chronic Disease

Single-dose Ad26.COV2.S vaccine provides moderate protection against Covid-19 related outcomes

May 13, 2022
Next Post

A sibling-adoption design for the study of genetic and environmental influence on children’s body mass index #TA

A sibling-adoption design for the study of genetic and environmental influence on children’s body mass index #VA

A sibling-adoption design for the study of genetic and environmental influence on children's body mass index #VA

Late pregnancy pertussis vaccination may boost passive immunity

Postmarket surveillance programs largest source of safety data triggering vaccine label changes

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Early exposure to allergenic foods may reduce incidence of long-term food allergy
  • Risk of post-vitrectomy endophthalmitis may have increased during the COVID-19 pandemic
  • Bosniak classification system differentiates benign renal cysts from cystic carcinoma [Classics Series]
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.